Dysregulated protein glycosylation was clearly shown to cause defects in tumor immunity and suppression of the tumor immune response, but the clinical relevance of MGAT1 in breast cancer immune evasion remains unknown. This evidence concerns the gene MGAT1 and neoplasm.